ASCO: Breast Cancer Brain Mets Treated with Tucatinib
Addition of agent to chemotherapy improves survival The risk of death or progression of brain...
Read More
Meeting Coverage
ASCO: Larotrectinib Produces Durable Responses
TRK fusion targets multiple cancers Patients diagnosed with a variety of advanced cancers —...
Read More
ASCO: Survival Benefit Emerges in ARAMIS
Darolutamide better in non-metastatic castration-resistant prostate cancer Men diagnosed with...
Read More
ASCO: Consultant Palliation Improves AML Quality of Life
Early referral linked to better psychological outcomes Referring a patient diagnosed with acute...
Read More
ASCO: Gastric Cancer Patients Respond to Trastuzumab Deruxtecan
Overall survival also extended with conjugate treatment In a small, phase II trial, patients with...
Read More
Mortality Rate 13% for Cancer Patients with COVID-19
MONDAY, June 1, 2020 (HealthDay News) — For patients with cancer and COVID-19, mortality is...
Read More
ASCO 2020: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, the oral...
Read More
Conference Highlights: AATS 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read More
Medical News Forecast for May 25-31
An FDA Covid-19 Town Hall, ASCO’s virtual meeting, upcoming drug approvals, and more Here is...
Read More
ASCO: Virtual Meeting Kicks Off May 29
Three days packed with presentations The American Society of Clinical Oncology is the leading...
Read More
Conference Highlights: Virtual SCAI 2020
New research was presented at SCAI 2020, the virtual Society for Cardiovascular Angiography &...
Read More
AACR 2020: Tumor Immune Biology Differs Between Metastatic & Early TNBC
Although research has linked pre-existing intratumoral immune response—characterized by presence...
Read More
AACR 2020: The Socioecological Context of Tobacco & Vape Shop Locations
Evidence suggests that, despite increased public health efforts to discourage teens from using...
Read More
AACR 2020: Pre-existing ESR1 Mutations Predict Endocrine Therapy Failure & Poor Survival
Despite research suggesting that mutation in ESR1 is an acquired mechanism of resistance to...
Read More
AACR 2020: Treatment Holiday Worsens PFS in BRAF-Mutant Melanoma
Although previous studies suggest objective responses with BRAF and MEK inhibitors in the majority...
Read More
AACR 2020: Cancer Ups COVID-19 Vulnerability
With prior research indicating that patients with cancer are generally more vulnerable to...
Read More
CROI 2020: Post-ACS Outcomes in PLHIV
Based on the hypothesis that HIV-infected individuals have higher rates of mortality following...
Read More
CROI 2020: Direct-Acting Antivirals & Healthcare Use
Empirical evidence supporting the cost savings associated with direct-acting antivirals (DAAs) in...
Read More
CROI 2020: HIV Stigma & Retention in Care
Although evidence indicates that HIV-related stigma appears to be a barrier to engagement in care,...
Read More
CROI 2020: Sustained Viral Suppression With Rapid Start in Young Patients
Although the linkage-to-care intervention Rapid Start—designed to start patients newly diagnosed...
Read More